A prospective, single-arm, multi-center, open label, pre-market, early feasibility clinical study designed to provide safety and efficacy data regarding the use of the Adagio System in the treatment of SMVT.~Study subjects will include patients who experience recurrent SMVT and are scheduled for an endocardial VT ablation.~Study subjects must have an Implantable Cardioverter Defibrillator (ICD) prior to the cryoablation procedure.
The objective of this clinical study is to evaluate the safety and performance of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic VT (SMVT)